3,292
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

ORCID Icon, , , , , , , , , , , , , , , , & ORCID Icon show all
Article: e1638210 | Received 03 Jan 2019, Accepted 25 Jun 2019, Published online: 13 Jul 2019